Evaluation of SCOUT DS in Subjects With Type 2 Diabetes (TCOYD)
The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.
Type 2 Diabetes
|Study Design:||Observational Model: Cohort
Time Perspective: Cross-Sectional
|Official Title:||An Evaluation of a Non-invasive Diabetes Screening Device in Subjects With Type 2 Diabetes|
- Validation of SCOUT DS algorithm for detecting known type 2 diabetes [ Time Frame: 1 day ] [ Designated as safety issue: No ]Collect SCOUT DS and Hemoglobin A1c measurements of subjects with Type 2 Diabetes
|Study Start Date:||October 2010|
|Study Completion Date:||October 2010|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
Those with Type 2 diabetes
All subjects have been diagnosed with type 2 diabetes.
Previous studies have excluded subjects with Type 2 diabetes. The primary objective of this study is to correct an imbalance in the disease prevalence of the data set used to develop the SCOUT DS diabetes screening algorithm.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01346033
|United States, California|
|San Diego Convention Center|
|San Diego, California, United States, 92111|
|Principal Investigator:||Martin L Kabongo, MD,PhD||Accelovance San Diego|